CLINICAL PRACTICE CONSIDERATIONS Long-term outcomes While strong evidence supports the kidney-protective effects of both SGLT2 inhibitors and GLP-1 receptor agonists, the long-term durability of these benefits remains uncertain (Table 2)
Data availability The datasets generated during and/or analysed during the current study are not publicly available but are available from the corresponding author on reasonable request
As a patient, that means your prescription is compounded individually after your provider writes it typically a few-day wait, with shipping usually limited to within Iowa, and dose customization often possible
Try to stay away from strong lighteners until at least 8 months
Many people describe it as a queasy feeling that comes and goes throughout the day
More importantly, anti-inflammatory and other currently available drugs do not completely stop the onset or progression of the disease and do not induce regeneration of neurons and its network connections in the affected brain regions